| Feature Type | Standardized | Nominal ANOVA | ||||
|---|---|---|---|---|---|---|
| mRNA | PLX4720 | GDSC1000 | pan-cancer | AAC | -0.0019 | 1 |
| mRNA | Gefitinib | GDSC1000 | pan-cancer | AAC | 0.002 | 1 |
| mRNA | salermide:PLX-4032 (12:1 mol/mol) | CTRPv2 | pan-cancer | AAC | -0.0022 | 1 |
| mRNA | WZ8040 | CTRPv2 | pan-cancer | AAC | 0.0023 | 1 |
| mRNA | CMK | GDSC1000 | pan-cancer | AAC | 0.0028 | 1 |
| mRNA | BRD8958 | CTRPv2 | pan-cancer | AAC | -0.0019 | 1 |
| mRNA | BRD-K16147474 | CTRPv2 | pan-cancer | AAC | -0.0018 | 1 |
| mRNA | PF-184 | CTRPv2 | pan-cancer | AAC | -0.0015 | 1 |
| mRNA | AT-7519 | GDSC1000 | pan-cancer | AAC | -0.0014 | 1 |
| mRNA | indisulam | CTRPv2 | pan-cancer | AAC | 0.0014 | 1 |